Cardinal Health Quarterly Income Statements Chart
Quarterly
|
Annual
Cardinal Health Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 60,159,000,000 | 54,878,000,000 | 55,264,000,000 | 52,277,000,000 | 59,708,000,000 | 54,911,000,000 | 57,445,000,000 | 54,763,000,000 | 53,453,000,000 | 50,487,000,000 | 51,469,000,000 | 49,603,000,000 | 47,103,000,000 | 44,836,000,000 | 45,457,000,000 | 43,968,000,000 | 42,586,000,000 | 39,275,000,000 | 41,541,000,000 | 39,065,000,000 | 36,689,000,000 | 39,157,000,000 | 39,735,000,000 | 37,341,000,000 | 37,353,000,000 | 35,228,000,000 | 37,740,000,000 | 35,213,000,000 | 35,349,000,000 | 33,633,000,000 | 35,186,000,000 | 32,641,000,000 | 32,966,000,000 | 31,821,000,000 | 33,150,000,000 | 32,039,000,000 | 31,384,000,000 | 30,662,000,000 | 31,445,000,000 | 28,055,000,000 | 27,548,000,000 | 25,375,000,000 | 25,537,000,000 | 24,070,000,000 | 22,894,000,000 | 21,427,000,000 | 22,240,000,000 | 24,523,000,000 | 25,420,000,000 | 24,552,000,000 | 25,232,000,000 | 25,889,000,000 | 26,764,500,000 | 26,917,500,000 | 27,078,000,000 | 26,792,000,000 | 26,763,500,000 | 26,071,400,000 | 25,371,800,000 | 24,437,500,000 | 24,459,600,000 | 24,342,800,000 | 24,919,700,000 | 24,780,700,000 | 25,127,000,000 | 24,938,700,000 | 25,099,500,000 | 24,347,200,000 | 22,925,600,000 | 22,909,600,000 | 23,282,700,000 | 21,973,400,000 | 22,262,900,000 | 21,867,100,000 | 21,784,600,000 | 21,356,700,000 | 21,708,300,000 | 20,637,500,000 | 19,919,000,000 | 19,373,400,000 | |
yoy | 0.76% | -0.06% | -3.80% | -4.54% | 11.70% | 8.76% | 11.61% | 10.40% | 13.48% | 12.60% | 13.23% | 12.82% | 10.61% | 14.16% | 9.43% | 12.55% | 16.07% | 0.30% | 4.55% | 4.62% | -1.78% | 11.15% | 5.29% | 6.04% | 5.67% | 4.74% | 7.26% | 7.88% | 7.23% | 5.69% | 6.14% | 1.88% | 5.04% | 3.78% | 5.42% | 14.20% | 13.92% | 20.84% | 23.14% | 16.56% | 20.33% | 18.43% | 14.82% | -1.85% | -9.94% | -12.73% | -11.86% | -5.28% | -5.02% | -8.79% | -6.82% | -3.37% | 0.00% | 3.25% | 6.72% | 9.63% | 9.42% | 7.10% | 1.81% | -1.38% | -2.66% | -2.39% | -0.72% | 1.78% | 9.60% | 8.86% | 7.80% | 10.80% | 2.98% | 4.77% | 6.88% | 2.89% | 2.55% | 5.96% | 9.37% | 10.24% | |||||
qoq | 9.62% | -0.70% | 5.71% | -12.45% | 8.74% | -4.41% | 4.90% | 2.45% | 5.87% | -1.91% | 3.76% | 5.31% | 5.06% | -1.37% | 3.39% | 3.25% | 8.43% | -5.45% | 6.34% | 6.48% | -6.30% | -1.45% | 6.41% | -0.03% | 6.03% | -6.66% | 7.18% | -0.38% | 5.10% | -4.41% | 7.80% | -0.99% | 3.60% | -4.01% | 3.47% | 2.09% | 2.35% | -2.49% | 12.08% | 1.84% | 8.56% | -0.63% | 6.09% | 5.14% | 6.85% | -3.66% | -9.31% | -3.53% | 3.54% | -2.69% | -2.54% | -3.27% | -0.57% | -0.59% | 1.07% | 0.11% | 2.65% | 2.76% | 3.82% | -0.09% | 0.48% | -2.32% | 0.56% | -1.38% | 0.76% | -0.64% | 3.09% | 6.20% | 0.07% | -1.60% | 5.96% | -1.30% | 1.81% | 0.38% | 2.00% | -1.62% | 5.19% | 3.61% | 2.82% | ||
cost of products sold | 57,957,000,000 | 52,755,000,000 | 53,323,000,000 | 50,375,000,000 | 57,855,000,000 | 52,964,000,000 | 55,599,000,000 | 52,995,000,000 | 51,626,000,000 | 48,702,000,000 | 49,806,000,000 | 47,989,000,000 | 45,498,000,000 | 43,154,000,000 | 43,841,000,000 | 42,326,000,000 | 41,111,000,000 | 37,463,000,000 | 39,765,000,000 | 37,350,000,000 | 35,099,000,000 | 37,272,000,000 | 38,021,000,000 | 35,662,000,000 | 35,679,000,000 | 33,464,000,000 | 36,010,000,000 | 33,546,000,000 | 33,614,000,000 | 31,720,000,000 | 33,325,000,000 | 30,969,000,000 | 31,343,000,000 | 30,093,000,000 | 31,548,000,000 | 30,449,000,000 | 29,718,000,000 | 28,973,000,000 | 29,836,000,000 | 26,476,000,000 | 26,090,000,000 | 23,916,000,000 | 24,083,000,000 | 22,729,000,000 | 21,638,000,000 | 20,130,000,000 | 20,895,000,000 | 23,259,000,000 | 24,172,000,000 | 23,261,000,000 | 24,008,000,000 | 24,730,000,000 | 25,628,500,000 | 25,710,800,000 | 25,964,100,000 | 25,707,500,000 | 25,720,200,000 | 24,909,200,000 | 24,377,600,000 | 23,475,300,000 | 23,555,500,000 | 23,332,700,000 | 23,962,000,000 | 23,871,900,000 | 23,783,200,000 | 23,537,000,000 | 23,683,100,000 | 22,982,700,000 | 21,456,200,000 | 21,441,800,000 | 21,928,100,000 | 20,631,200,000 | 20,905,400,000 | 20,479,600,000 | 20,484,700,000 | 20,057,800,000 | 20,280,900,000 | 19,268,300,000 | 18,611,800,000 | 18,160,200,000 | |
gross margin | 2,202,000,000 | 2,123,000,000 | 1,941,000,000 | 1,902,000,000 | 1,853,000,000 | 1,947,000,000 | 1,846,000,000 | 1,768,000,000 | 1,827,000,000 | 1,785,000,000 | 1,663,000,000 | 1,614,000,000 | 1,605,000,000 | 1,682,000,000 | 1,616,000,000 | 1,642,000,000 | 1,475,000,000 | 1,812,000,000 | 1,776,000,000 | 1,715,000,000 | 1,590,000,000 | 1,885,000,000 | 1,714,000,000 | 1,679,000,000 | 1,674,000,000 | 1,764,000,000 | 1,730,000,000 | 1,667,000,000 | 1,735,000,000 | 1,913,000,000 | 1,861,000,000 | 1,672,000,000 | 1,623,000,000 | 1,728,000,000 | 1,602,000,000 | 1,590,000,000 | 1,666,000,000 | 1,689,000,000 | 1,609,000,000 | 1,579,000,000 | 1,458,000,000 | 1,459,000,000 | 1,454,000,000 | 1,341,000,000 | 1,256,000,000 | 1,297,000,000 | 1,345,000,000 | 1,264,000,000 | 1,248,000,000 | 1,291,000,000 | 1,224,000,000 | 1,159,000,000 | 1,136,000,000 | 1,206,700,000 | 1,113,900,000 | 1,084,500,000 | 1,043,300,000 | 1,162,200,000 | 994,200,000 | 962,200,000 | 904,100,000 | 1,010,100,000 | 957,700,000 | 908,800,000 | 1,343,800,000 | 1,401,700,000 | 1,416,400,000 | 1,364,500,000 | 1,469,400,000 | 1,467,800,000 | 1,354,600,000 | 1,342,200,000 | 1,357,500,000 | 1,387,500,000 | 1,299,900,000 | 1,298,900,000 | 1,427,400,000 | 1,369,200,000 | 1,307,200,000 | 1,213,200,000 | |
yoy | 18.83% | 9.04% | 5.15% | 7.58% | 1.42% | 9.08% | 11.00% | 9.54% | 13.83% | 6.12% | 2.91% | -1.71% | 8.81% | -7.17% | -9.01% | -4.26% | -7.23% | -3.87% | 3.62% | 2.14% | -5.02% | 6.86% | -0.92% | 0.72% | -3.52% | -7.79% | -7.04% | -0.30% | 6.90% | 10.71% | 16.17% | 5.16% | -2.58% | 2.31% | -0.44% | 0.70% | 14.27% | 15.76% | 10.66% | 17.75% | 16.08% | 12.49% | 8.10% | 6.09% | 0.64% | 0.46% | 9.89% | 9.06% | 9.86% | 6.99% | 9.88% | 6.87% | 8.89% | 3.83% | 12.04% | 12.71% | 15.40% | 15.06% | 3.81% | 5.88% | -32.72% | -27.94% | -32.38% | -33.40% | -8.55% | -4.50% | 4.56% | 1.66% | 8.24% | 5.79% | 4.21% | 3.33% | -4.90% | 1.34% | -0.56% | 7.06% | |||||
qoq | 3.72% | 9.38% | 2.05% | 2.64% | -4.83% | 5.47% | 4.41% | -3.23% | 2.35% | 7.34% | 3.04% | 0.56% | -4.58% | 4.08% | -1.58% | 11.32% | -18.60% | 2.03% | 3.56% | 7.86% | -15.65% | 9.98% | 2.08% | 0.30% | -5.10% | 1.97% | 3.78% | -3.92% | -9.30% | 2.79% | 11.30% | 3.02% | -6.08% | 7.87% | 0.75% | -4.56% | -1.36% | 4.97% | 1.90% | 8.30% | -0.07% | 0.34% | 8.43% | 6.77% | -3.16% | -3.57% | 6.41% | 1.28% | -3.33% | 5.47% | 5.61% | 2.02% | -5.86% | 8.33% | 2.71% | 3.95% | -10.23% | 16.90% | 3.33% | 6.43% | -10.49% | 5.47% | 5.38% | -32.37% | -4.13% | -1.04% | 3.80% | -7.14% | 0.11% | 8.36% | 0.92% | -1.13% | -2.16% | 6.74% | 0.08% | -9.00% | 4.25% | 4.74% | 7.75% | ||
gross margin % | 3.66% | 3.87% | 3.51% | 3.64% | 3.10% | 3.55% | 3.21% | 3.23% | 3.42% | 3.54% | 3.23% | 3.25% | 3.41% | 3.75% | 3.56% | 3.73% | 3.46% | 4.61% | 4.28% | 4.39% | 4.33% | 4.81% | 4.31% | 4.50% | 4.48% | 5.01% | 4.58% | 4.73% | 4.91% | 5.69% | 5.29% | 5.12% | 4.92% | 5.43% | 4.83% | 4.96% | 5.31% | 5.51% | 5.12% | 5.63% | 5.29% | 5.75% | 5.69% | 5.57% | 5.49% | 6.05% | 6.05% | 5.15% | 4.91% | 5.26% | 4.85% | 4.48% | 4.24% | 4.48% | 4.11% | 4.05% | 3.90% | 4.46% | 3.92% | 3.94% | 3.70% | 4.15% | 3.84% | 3.67% | 5.35% | 5.62% | 5.64% | 5.60% | 6.41% | 6.41% | 5.82% | 6.11% | 6.10% | 6.35% | 5.97% | 6.08% | 6.58% | 6.63% | 6.56% | 6.26% | |
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution, selling, general and administrative expenses | 974,500,000 | 1,315,000,000 | 1,306,000,000 | 1,277,000,000 | 1,238,000,000 | 1,282,000,000 | 1,283,000,000 | 1,197,000,000 | 1,267,000,000 | 1,179,000,000 | 1,191,000,000 | 1,197,000,000 | 1,155,000,000 | 1,137,000,000 | 1,151,000,000 | 1,114,000,000 | 1,129,000,000 | 1,120,000,000 | 1,147,000,000 | 1,137,000,000 | 1,137,000,000 | 1,165,000,000 | 1,163,000,000 | 1,107,000,000 | 1,165,000,000 | 1,097,000,000 | 1,064,000,000 | 1,155,000,000 | 1,271,000,000 | 1,132,000,000 | 1,131,000,000 | 1,062,000,000 | 983,000,000 | 960,000,000 | 847,000,000 | 803,000,000 | 815,000,000 | 775,000,000 | 795,000,000 | 736,000,000 | 766,000,000 | 732,000,000 | 776,000,000 | 712,000,000 | 699,000,000 | 690,000,000 | 643,300,000 | 591,900,000 | 588,200,000 | 628,600,000 | 605,200,000 | 586,100,000 | |||||||||||||||||||||||||||||
restructuring and employee severance | 27,000,000 | 28,000,000 | 9,000,000 | 24,000,000 | 69,000,000 | 53,000,000 | 28,000,000 | 25,000,000 | 33,000,000 | 16,000,000 | 17,000,000 | 29,000,000 | 45,000,000 | 31,000,000 | 7,000,000 | 18,000,000 | 33,000,000 | 24,000,000 | 20,000,000 | 37,000,000 | 42,000,000 | -6,000,000 | 56,000,000 | 30,000,000 | 28,000,000 | 53,000,000 | 12,000,000 | 32,000,000 | 21,000,000 | 2,000,000 | 21,000,000 | 132,000,000 | 25,000,000 | 15,000,000 | 7,000,000 | 9,000,000 | 6,000,000 | 6,000,000 | 2,000,000 | 12,000,000 | 11,000,000 | 7,000,000 | 7,000,000 | 19,000,000 | 6,000,000 | 5,000,000 | 10,000,000 | 11,000,000 | 32,000,000 | 33,000,000 | 1,000,000 | 5,000,000 | 8,800,000 | 7,100,000 | 1,700,000 | 3,400,000 | 4,900,000 | 6,200,000 | 2,600,000 | 1,800,000 | 6,300,000 | 13,900,000 | 10,700,000 | 59,700,000 | |||||||||||||||||
amortization and other acquisition-related costs | 133,000,000 | 152,000,000 | 105,000,000 | 74,000,000 | 77,000,000 | 80,000,000 | 63,000,000 | 64,000,000 | 69,000,000 | 74,000,000 | 71,000,000 | 71,000,000 | 87,000,000 | 79,000,000 | 79,000,000 | 79,000,000 | 106,000,000 | 111,000,000 | 116,000,000 | 118,000,000 | 129,000,000 | 130,000,000 | 133,000,000 | 132,000,000 | 153,000,000 | 154,000,000 | 157,000,000 | 156,000,000 | 164,000,000 | 175,000,000 | 184,000,000 | 183,000,000 | 162,000,000 | 128,000,000 | 115,000,000 | 122,000,000 | 132,000,000 | 108,000,000 | 114,000,000 | 105,000,000 | 91,000,000 | 77,000,000 | 60,000,000 | 53,000,000 | 63,000,000 | 56,000,000 | 56,000,000 | 49,000,000 | |||||||||||||||||||||||||||||||||
acquisition-related cash and share-based compensation costs | 106,000,000 | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairments and (gain)/loss on disposal of assets | 33,000,000 | -17,000,000 | 3,000,000 | -1,000,000 | 12,000,000 | 84,000,000 | 1,000,000 | 537,000,000 | 367,000,000 | 20,000,000 | 710,000,000 | 153,000,000 | 286,000,000 | 471,000,000 | 1,295,000,000 | -2,000,000 | 1,000,000 | 69,000,000 | 9,000,000 | -1,000,000 | 7,000,000 | 1,000,000 | 4,000,000 | 11,000,000 | 8,000,000 | -511,000,000 | 1,355,000,000 | -6,000,000 | 1,000,000 | 3,000,000 | 4,000,000 | 17,000,000 | -1,000,000 | -18,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
litigation (recoveries)/charges | -9,000,000 | -105,000,000 | -31,000,000 | -40,000,000 | 49,000,000 | 81,000,000 | -11,000,000 | -41,000,000 | -46,000,000 | -76,000,000 | -207,000,000 | 27,000,000 | -4,000,000 | 61,000,000 | 34,000,000 | 18,000,000 | 44,000,000 | 15,000,000 | 32,000,000 | 1,038,000,000 | 12,000,000 | 35,000,000 | 21,000,000 | 5,673,000,000 | 16,000,000 | 17,000,000 | -15,000,000 | 19,000,000 | 4,000,000 | 64,000,000 | 58,000,000 | 32,000,000 | 11,000,000 | 18,000,000 | 19,000,000 | 1,000,000 | -66,000,000 | 5,000,000 | -9,000,000 | -49,000,000 | -18,000,000 | 44,000,000 | 28,000,000 | -8,000,000 | -15,000,000 | 1,000,000 | -1,000,000 | -3,000,000 | -12,000,000 | -22,000,000 | 200,000 | -200,000 | 100,000 | -3,200,000 | |||||||||||||||||||||||||||
operating earnings | 428,000,000 | 730,000,000 | 549,000,000 | 208,750,000 | 367,000,000 | 137,000,000 | 308,000,000 | 432,000,000 | 504,000,000 | 816,000,000 | -1,080,000,000 | 546,000,000 | 399,000,000 | 262,000,000 | 439,000,000 | 605,000,000 | 542,000,000 | 535,000,000 | 620,000,000 | 656,000,000 | 563,000,000 | 620,000,000 | 558,000,000 | 591,000,000 | 546,000,000 | 466,000,000 | 387,000,000 | 508,000,000 | 519,000,000 | 471,000,000 | -443,000,000 | 475,000,000 | 506,000,000 | 457,000,000 | 403,800,000 | 526,600,000 | 449,300,000 | 412,300,000 | 358,900,000 | 447,300,000 | 343,900,000 | 363,900,000 | 333,900,000 | 366,300,000 | 366,800,000 | 239,900,000 | 425,200,000 | 496,300,000 | 537,900,000 | 426,300,000 | 519,200,000 | 489,800,000 | 512,100,000 | 463,700,000 | 534,300,000 | 559,400,000 | 484,400,000 | 372,400,000 | |||||||||||||||||||||||
other (income)/expense | -30,000,000 | -9,000,000 | 3,000,000 | -5,000,000 | 16,000,000 | -7,000,000 | -16,000,000 | -2,000,000 | 1,000,000 | -7,000,000 | 2,000,000 | 30,000,000 | 3,000,000 | -13,000,000 | -4,000,000 | -16,000,000 | -12,000,000 | -12,000,000 | -7,000,000 | -22,000,000 | 19,000,000 | -12,000,000 | 14,000,000 | 2,000,000 | -13,000,000 | 21,000,000 | 3,000,000 | 29,000,000 | -2,000,000 | -5,000,000 | 2,000,000 | -3,000,000 | -5,000,000 | 7,000,000 | -3,000,000 | -2,000,000 | 8,000,000 | -4,000,000 | -8,000,000 | 800,000 | 3,800,000 | 2,200,000 | -1,400,000 | -25,600,000 | -8,900,000 | ||||||||||||||||||||||||||||||||||||
interest expense | 74,000,000 | 74,000,000 | 35,000,000 | 32,000,000 | -4,000,000 | 33,000,000 | 8,000,000 | 14,000,000 | 15,000,000 | 28,000,000 | 25,000,000 | 25,000,000 | 34,000,000 | 38,000,000 | 37,000,000 | 40,000,000 | 44,000,000 | 45,000,000 | 46,000,000 | 45,000,000 | 49,000,000 | 60,000,000 | 63,000,000 | 66,000,000 | 67,000,000 | 75,000,000 | 76,000,000 | 77,000,000 | 78,000,000 | 84,000,000 | 87,000,000 | 81,000,000 | 67,000,000 | 46,000,000 | 44,000,000 | 44,000,000 | 44,000,000 | 44,000,000 | 45,000,000 | 44,000,000 | 36,000,000 | 35,000,000 | 36,000,000 | 34,000,000 | 33,000,000 | 34,000,000 | 33,000,000 | 33,000,000 | 36,000,000 | 34,000,000 | 27,000,000 | 26,000,000 | 24,800,000 | 23,900,000 | 22,900,000 | 23,500,000 | 23,800,000 | 25,100,000 | 21,900,000 | 22,000,000 | 24,600,000 | 27,700,000 | 27,400,000 | 33,900,000 | |||||||||||||||||
earnings before income taxes | 384,000,000 | 665,000,000 | 511,000,000 | 201,250,000 | 341,000,000 | 110,000,000 | 378,000,000 | 370,000,000 | 407,000,000 | 736,000,000 | 239,750,000 | 464,000,000 | 317,000,000 | 178,000,000 | 387,250,000 | 564,000,000 | 491,000,000 | 494,000,000 | 425,000,000 | 612,000,000 | 520,000,000 | 568,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | 141,000,000 | 157,000,000 | 110,000,000 | 162,000,000 | 82,000,000 | -32,000,000 | 47,250,000 | 197,000,000 | -7,000,000 | -1,022,000,000 | -423,000,000 | 142,000,000 | 61,000,000 | 97,000,000 | 182,000,000 | 167,000,000 | 184,000,000 | 241,000,000 | 226,000,000 | 194,000,000 | 184,000,000 | 231,000,000 | 193,000,000 | 162,000,000 | 169,000,000 | 123,000,000 | 192,000,000 | 217,000,000 | 102,000,000 | 105,000,000 | 101,000,000 | 180,000,000 | 167,000,000 | 140,900,000 | 177,900,000 | 161,200,000 | 147,900,000 | 133,900,000 | 175,600,000 | 112,800,000 | 129,800,000 | 114,600,000 | 138,400,000 | 134,800,000 | 236,800,000 | 131,100,000 | 122,400,000 | 156,600,000 | 114,100,000 | 144,100,000 | 143,700,000 | 164,000,000 | 115,700,000 | 162,200,000 | 169,200,000 | 146,500,000 | 106,100,000 | ||||||||||||||||||||||||
net earnings | 243,000,000 | 508,000,000 | 401,000,000 | 154,750,000 | 259,000,000 | 6,000,000 | 111,000,000 | 49,000,000 | 195,000,000 | 296,000,000 | 281,000,000 | 594,000,000 | -1,166,000,000 | 255,000,000 | 1,053,000,000 | 117,000,000 | 278,000,000 | 382,000,000 | 324,000,000 | 310,000,000 | 335,000,000 | 386,000,000 | 326,000,000 | 384,000,000 | 295,000,000 | 365,000,000 | 289,000,000 | 266,000,000 | 234,000,000 | 315,000,000 | 278,000,000 | 339,000,000 | -586,000,000 | 345,000,000 | 303,000,000 | 271,000,000 | 236,800,000 | 333,400,000 | 262,000,000 | 236,800,000 | 202,700,000 | 246,000,000 | 215,400,000 | 223,500,000 | 222,400,000 | 234,500,000 | 273,200,000 | 312,900,000 | 316,500,000 | 249,100,000 | 318,000,000 | 356,000,000 | 324,700,000 | 301,800,000 | 902,200,000 | 19,000,000 | 739,300,000 | 270,700,000 | 321,000,000 | 146,800,000 | 304,000,000 | 228,300,000 | |||||||||||||||||||
less: net earnings attributable to noncontrolling interests | -4,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | 2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | 2,000,000 | -2,000,000 | -1,000,000 | 1,000,000 | -1,000,000 | -1,000,000 | 1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -4,000,000 | -1,000,000 | -1,000,000 | -3,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net earnings attributable to cardinal health, inc. | 239,000,000 | 506,000,000 | 400,000,000 | 154,000,000 | 258,000,000 | 5,000,000 | 110,000,000 | 49,000,000 | 194,000,000 | 296,000,000 | 280,000,000 | 593,000,000 | -1,166,000,000 | 255,000,000 | 1,053,000,000 | 115,000,000 | 274,000,000 | 381,000,000 | 324,000,000 | 309,000,000 | 332,000,000 | 386,000,000 | 326,000,000 | 383,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share attributable to cardinal health, inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1,010,000 | 2,110,000 | 1,650,000 | 627,500 | 1,060,000 | 20,000 | 410,000 | 170,000 | 660,000 | 990,000 | 940,000 | 1,950,000 | -3,700,000 | 810,000 | 3,350,000 | 360,000 | 797,500 | 1,210,000 | 1,020,000 | 970,000 | 832,500 | 1,180,000 | 990,000 | 1,170,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1,010,000 | 2,100,000 | 1,650,000 | 622,500 | 1,050,000 | 20,000 | 400,000 | 170,000 | 650,000 | 990,000 | 930,000 | 1,940,000 | -3,690,000 | 810,000 | 3,330,000 | 360,000 | 792,500 | 1,200,000 | 1,020,000 | 960,000 | 825,000 | 1,170,000 | 980,000 | 1,150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 241,000,000 | 240,000,000 | 242,000,000 | 243,000,000 | 245,000,000 | 243,000,000 | 245,000,000 | 249,000,000 | 261,000,000 | 256,000,000 | 261,000,000 | 271,000,000 | 279,000,000 | 275,000,000 | 279,000,000 | 287,000,000 | 292,000,000 | 292,000,000 | 294,000,000 | 293,000,000 | 293,000,000 | 292,000,000 | 292,000,000 | 296,000,000 | 300,000,000 | 298,000,000 | 299,000,000 | 305,000,000 | 313,000,000 | 313,000,000 | 315,000,000 | 316,000,000 | 317,000,000 | 316,000,000 | 318,000,000 | 320,000,000 | 327,000,000 | 328,000,000 | 329,000,000 | 328,000,000 | 332,000,000 | 330,000,000 | 331,000,000 | 336,000,000 | 341,000,000 | 342,000,000 | 342,000,000 | 340,000,000 | 341,000,000 | 341,000,000 | 340,000,000 | 341,000,000 | 345,000,000 | 345,300,000 | 345,000,000 | 344,800,000 | 348,600,000 | 348,500,000 | 347,600,000 | 348,900,000 | 358,800,000 | 358,700,000 | 359,000,000 | 359,100,000 | 357,600,000 | 358,100,000 | 357,300,000 | 356,700,000 | 358,200,000 | 355,500,000 | 358,700,000 | 363,000,000 | 394,900,000 | 394,600,000 | 402,200,000 | 404,500,000 | 421,200,000 | 419,100,000 | 425,500,000 | 426,300,000 | |
diluted | 242,000,000 | 241,000,000 | 243,000,000 | 245,000,000 | 247,000,000 | 245,000,000 | 246,000,000 | 250,000,000 | 262,000,000 | 258,000,000 | 261,000,000 | 273,000,000 | 279,000,000 | 275,000,000 | 281,000,000 | 289,000,000 | 294,000,000 | 294,000,000 | 295,000,000 | 293,000,000 | 293,000,000 | 294,000,000 | 294,000,000 | 296,000,000 | 301,000,000 | 299,000,000 | 300,000,000 | 306,000,000 | 315,000,000 | 315,000,000 | 316,000,000 | 318,000,000 | 320,000,000 | 318,000,000 | 319,000,000 | 322,000,000 | 330,000,000 | 331,000,000 | 332,000,000 | 331,000,000 | 335,000,000 | 334,000,000 | 334,000,000 | 340,000,000 | 345,000,000 | 347,000,000 | 346,000,000 | 344,000,000 | 344,000,000 | 345,000,000 | 343,000,000 | 344,000,000 | 349,000,000 | 349,500,000 | 348,800,000 | 349,400,000 | 352,500,000 | 352,900,000 | 350,700,000 | 351,900,000 | 361,400,000 | 361,800,000 | 361,000,000 | 359,100,000 | 361,500,000 | 360,900,000 | 360,300,000 | 361,100,000 | 364,000,000 | 360,200,000 | 364,600,000 | 370,200,000 | 404,700,000 | 394,600,000 | 410,600,000 | 413,000,000 | 428,500,000 | 427,500,000 | 431,900,000 | 431,400,000 | |
cash dividends declared per common share | 379,200 | 505,600 | 505,600 | 505,600 | 375,450 | 500,600 | 500,600 | 500,600 | 371,775 | 495,700 | 495,700 | 495,700 | 368,100 | 490,800 | 490,800 | 490,800 | 364,425 | 485,900 | 485,900 | 485,900 | 360,825 | 481,100 | 481,100 | 481,100 | 357,225 | 476,300 | 476,300 | 476,300 | 346,800 | 462,400 | 462,400 | 462,400 | 336,675 | 448,900 | 448,900 | 448,900 | 290,250 | 387,000 | 387,000 | 387,000 | 256,875 | 342,500 | 342,500 | 342,500 | 226,875 | 302,500 | 302,500 | 302,500 | 196,875 | 275,000 | 275,000 | 237,500 | 161,250 | 215,000 | 215,000 | 215,000 | 146,250 | 195,000 | 195,000 | 195,000 | 131,250 | 175,000 | 175,000 | 175,000 | 105,000 | 140,000 | 140,000 | 140,000 | 90,000 | 120,000 | 120,000 | 120,000 | 67,500 | 90,000 | 90,000 | 90,000 | 45,000 | 60,000 | 60,000 | 60,000 | |
operating earnings/ | 568,000,000 | 482,000,000 | -14,000,000 | 137,000,000 | 572,000,000 | -119,000,000 | 36,000,000 | -97,000,000 | -950,000,000 | 415,000,000 | 162,000,000 | 473,000,000 | 461,000,000 | 270,000,000 | 562,000,000 | 334,000,000 | -5,264,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings/(loss) before income taxes | 541,000,000 | 490,000,000 | -26,000,000 | 121,000,000 | 544,000,000 | -28,000,000 | -137,000,000 | -973,000,000 | 369,000,000 | 119,000,000 | 440,000,000 | 427,000,000 | 815,000,000 | 478,000,000 | 279,000,000 | -5,344,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from/(benefit from) income taxes | 124,000,000 | 136,000,000 | -1,000,000 | -165,000,000 | 1,253,000,000 | 97,000,000 | 4,000,000 | 320,000,000 | -203,000,000 | -410,000,000 | 158,000,000 | 127,000,000 | 59,000,000 | 44,000,000 | 74,000,000 | 126,000,000 | -21,000,000 | 209,000,000 | -736,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net earnings/ | 417,000,000 | 354,000,000 | -66,000,000 | 347,000,000 | -130,000,000 | 137,000,000 | -1,390,000,000 | 272,000,000 | 115,000,000 | 120,000,000 | 630,000,000 | 657,000,000 | 351,000,000 | 220,000,000 | -4,921,000,000 | 294,800,000 | -38,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net earnings/(loss) attributable to cardinal health, inc. | 416,000,000 | 353,000,000 | -64,000,000 | 345,000,000 | -130,000,000 | 138,000,000 | -1,391,000,000 | 271,000,000 | 116,000,000 | 119,000,000 | 629,000,000 | 656,000,000 | 350,000,000 | 220,000,000 | -4,922,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings/(loss) per common share attributable to cardinal health, inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1,710,000 | 1,440,000 | -240,000 | 1,350,000 | -500,000 | 470,000 | -5,050,000 | 940,000 | 400,000 | 410,000 | 2,140,000 | 2,230,000 | 1,200,000 | 750,000 | -16,650,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1,700,000 | 1,430,000 | -230,000 | 1,340,000 | -500,000 | 470,000 | -5,050,000 | 940,000 | 400,000 | 400,000 | 2,130,000 | 2,230,000 | 1,190,000 | 750,000 | -16,650,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 10,000,000 | 13,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain)/loss on sale of equity interest in navihealth | -1,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | -137,000,000 | -663,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating income | -624,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1.60% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
net income | -253,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.65% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
net income attributable to cardinal health, inc. | -253,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share attributable to cardinal health, inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -860,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | -860,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 2,250,000 | 5,000,000 | 4,000,000 | 1,000,000 | 60,000,000 | 0 | 0 | 0 | 0 | 39,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairments and loss on disposal of assets | 68,000,000 | 3,750,000 | 2,000,000 | 9,000,000 | 5,000,000 | 9,000,000 | 832,000,000 | 21,000,000 | 5,000,000 | 1,000,000 | 1,600,000 | 17,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution, selling, general, and administrative expenses | 910,000,000 | 920,000,000 | 970,000,000 | 914,000,000 | 922,000,000 | 842,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | -1,000,000 | -2,000,000 | -1,000,000 | -3,000,000 | -3,000,000 | -33,000,000 | -6,000,000 | -4,000,000 | 2,000,000 | -6,000,000 | 2,000,000 | -7,700,000 | -4,850,000 | -6,200,000 | -5,800,000 | -7,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings before income taxes and discontinued operations | 523,000,000 | 558,000,000 | 451,000,000 | 435,000,000 | 357,000,000 | 507,000,000 | 492,000,000 | 442,000,000 | -481,000,000 | 447,000,000 | 483,000,000 | 439,000,000 | 377,000,000 | 510,400,000 | 425,600,000 | 385,000,000 | 341,300,000 | 425,100,000 | 327,800,000 | 424,200,000 | 308,400,000 | 363,200,000 | 365,000,000 | 175,000,000 | 391,800,000 | 435,900,000 | 475,500,000 | 363,900,000 | 469,200,000 | 446,900,000 | 479,700,000 | 416,000,000 | 333,500,000 | 525,000,000 | 450,500,000 | 340,700,000 | |||||||||||||||||||||||||||||||||||||||||||||
earnings from continuing operations | 292,000,000 | 365,000,000 | 289,000,000 | 266,000,000 | 234,000,000 | 315,000,000 | 275,000,000 | 340,000,000 | -586,000,000 | 346,000,000 | 303,000,000 | 272,000,000 | 236,100,000 | 332,500,000 | 264,400,000 | 237,100,000 | 207,400,000 | 249,500,000 | 215,000,000 | 193,800,000 | 224,800,000 | 230,200,000 | 260,700,000 | 313,500,000 | 318,900,000 | 249,800,000 | 325,100,000 | 303,200,000 | 315,700,000 | 300,300,000 | 226,475,000 | 355,800,000 | 304,000,000 | 234,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||
earnings from discontinued operations, net of tax | 3,000,000 | 400,000 | 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 880,000 | 1,100,000 | 870,000 | 790,000 | 690,000 | 920,000 | 800,000 | 1,000,000 | -1,720,000 | 1,010,000 | 890,000 | 800,000 | 680,000 | 960,000 | 770,000 | 690,000 | 590,000 | 720,000 | 620,000 | 840,000 | 540,000 | 630,000 | 640,000 | -170,000 | 730,000 | 880,000 | 890,000 | 700,000 | 900,000 | 1,030,000 | 910,000 | 830,000 | 630,000 | -10,000 | 780,000 | 740,000 | 820,000 | 850,000 | 710,000 | 550,000 | |||||||||||||||||||||||||||||||||||||||||
discontinued operations | 10,000 | -2,500 | 0 | -10,000 | 0 | -10,000 | -10,000 | 0 | 0 | 80,000 | -10,000 | 10,000 | 60,000 | 30,000 | -10,000 | -30,000 | 1,690,000 | 60,000 | 1,060,000 | -70,000 | -40,000 | -500,000 | -10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net basic earnings per common share | 890,000 | 1,100,000 | 870,000 | 790,000 | 690,000 | 920,000 | 810,000 | 1,000,000 | -1,720,000 | 1,010,000 | 890,000 | 800,000 | 690,000 | 960,000 | 760,000 | 690,000 | 580,000 | 710,000 | 620,000 | 620,000 | 620,000 | 650,000 | 760,000 | 880,000 | 890,000 | 700,000 | 890,000 | 1,000,000 | 910,000 | 830,000 | 2,320,000 | 50,000 | 1,840,000 | 670,000 | 780,000 | 350,000 | 710,000 | 540,000 | |||||||||||||||||||||||||||||||||||||||||||
diluted earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net diluted earnings per common share | 880,000 | 1,090,000 | 860,000 | 780,000 | 680,000 | 910,000 | 800,000 | 990,000 | -1,700,000 | 1,000,000 | 880,000 | 790,000 | 680,000 | 950,000 | 750,000 | 680,000 | 570,000 | 700,000 | 610,000 | 610,000 | 610,000 | 650,000 | 750,000 | 870,000 | 880,000 | 690,000 | 880,000 | 990,000 | 890,000 | 820,000 | 2,260,000 | 50,000 | 1,800,000 | 660,000 | 750,000 | 340,000 | 700,000 | 530,000 | |||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | -1,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings/(loss) from discontinued operations, net of tax | -250,000 | -1,000,000 | 700,000 | 900,000 | -2,400,000 | -300,000 | -4,700,000 | -3,500,000 | 6,375,000 | -2,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings/(loss) per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition-related costs | 52,000,000 | 53,000,000 | 25,000,000 | 28,000,000 | 10,200,000 | -26,600,000 | 21,900,000 | 27,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings/(loss) per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution, selling, general and administrative expense | 491,400,000 | 682,700,000 | 639,800,000 | 477,775,000 | 697,300,000 | 621,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain)/loss on sale of investment in carefusion | 0 | -17,875,000 | 3,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairments and loss on sale of assets | 1,100,000 | 1,300,000 | 400,000 | 4,600,000 | 1,700,000 | 1,900,000 | 7,050,000 | 4,200,000 | 400,000 | 23,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investment in carefusion | 0 | 0 | 0 | -74,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition related costs | 5,450,000 | 2,500,000 | 18,000,000 | 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation (credits)/charges | 2,975,000 | 4,300,000 | 6,100,000 | 1,400,000 | -33,600,000 | -2,900,000 | -25,400,000 | -500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings/(loss) from continuing operations | 294,400,000 | -61,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net basic earnings/(loss) per common share | 840,000 | -110,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net diluted earnings/(loss) per common share | 840,000 | -110,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of carefusion common stock | -1,300,000 | -23,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings from discontinued operations | 4,300,000 | 23,600,000 | 423,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
selling, general and administrative expenses | 854,100,000 | 850,200,000 | 851,900,000 | 882,200,000 | 901,300,000 | 854,500,000 | 828,900,000 | 830,100,000 | 819,300,000 | 781,700,000 | 755,600,000 | 807,300,000 | 853,900,000 | 778,600,000 | 796,700,000 | 815,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairments, (gain)/loss on sale of assets and other | 11,500,000 | 3,000,000 | 6,900,000 | 3,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
special items – restructuring charges | 28,025,000 | 48,100,000 | 14,200,000 | 31,500,000 | 14,800,000 | 7,100,000 | 6,600,000 | 10,000,000 | 13,400,000 | 9,825,000 | 20,600,000 | 14,400,000 | 9,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– acquisition integration charges | 2,950,000 | 3,500,000 | 5,800,000 | 10,000,000 | 5,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– litigation and other | 125,000 | 600,000 | -300,000 | -12,000,000 | 2,300,000 | 152,850,000 | 602,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense and other | 33,400,000 | 60,400,000 | 62,400,000 | 62,400,000 | 47,400,000 | 31,100,000 | 50,000,000 | 42,900,000 | 19,200,000 | 32,200,000 | 32,400,000 | 47,700,000 | 33,300,000 | 34,400,000 | 33,900,000 | 31,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
losses from discontinued operations | -925,000 | -600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | -2,400,000 | -700,000 | -1,400,000 | -29,600,000 | -17,800,000 | -209,000,000 | -6,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
special items | 49,700,000 | 13,675,000 | 8,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges and other | -5,500,000 | 1,200,000 | -23,000,000 | -200,000 | -600,000 | 3,600,000 | 12,600,000 | 3,600,000 | 4,400,000 | 8,200,000 | 5,100,000 | 2,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating earnings / | 396,375,000 | 576,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings / (loss) before income taxes and discontinued operations | 365,375,000 | 545,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision / (benefit) for income taxes | 116,800,000 | 179,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings / (loss) from continuing operations | 248,575,000 | 365,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings / | -2,925,000 | -9,900,000 | 106,725,000 | 23,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings / (loss) per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings / (loss) per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings/ | -400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– merger-related costs | 3,500,000 | 2,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating (loss) / earnings | 238,275,000 | -9,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(loss) / earnings before income taxes and discontinued operations | 212,725,000 | -42,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(benefit) / benefit from income taxes | 62,225,000 | -37,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(loss) / earnings from continuing operations | 150,500,000 | -4,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– merger charges | 9,100,000 | 5,200,000 | 7,500,000 | 7,500,000 | 7,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– other | 500,000 | 8,400,000 | -50,000 | -5,100,000 | -900,000 | 5,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
– merger related charges | 2,500,000 |
We provide you with 20 years income statements for Cardinal Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cardinal Health stock. Explore the full financial landscape of Cardinal Health stock with our expertly curated income statements.
The information provided in this report about Cardinal Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.